Vik Chopra

Stock Analyst at BMO Capital

(2.38)
# 3,024
Out of 5,074 analysts
232
Total ratings
44.2%
Success rate
1.2%
Average return

Stocks Rated by Vik Chopra

Integra LifeSciences Holdings
Oct 22, 2026
Reiterated: Hold
Price Target: $15 → $14
Current: $12.33
Upside: +13.59%
Intuitive Surgical
Oct 20, 2026
Rated: Buy
Price Target: $518
Current: $443.85
Upside: +16.71%
Stryker
Oct 12, 2026
Reiterated: Buy
Price Target: $317
Current: $307.08
Upside: +3.23%
Envista Holdings
Sep 28, 2026
Reiterated: Hold
Price Target: $29 → $26
Current: $23.97
Upside: +8.47%
DENTSPLY SIRONA
Sep 16, 2026
Rated: Hold
Price Target: $13 → $10
Current: $9.50
Upside: +5.26%
GE HealthCare Technologies
Sep 13, 2026
Reiterated: Hold
Price Target: $71
Current: $71.42
Upside: -0.59%
Enovis
Sep 1, 2026
Rated: Buy
Price Target: $30 → $27
Current: $21.59
Upside: +25.06%
Globus Medical
Aug 27, 2026
Reiterated: Buy
Price Target: $94
Current: $81.66
Upside: +15.11%
Solventum
Aug 17, 2026
Reiterated: Hold
Price Target: $84
Current: $87.45
Upside: -3.95%
Align Technology
Aug 12, 2026
Reiterated: Buy
Price Target: $209
Current: $155.51
Upside: +34.40%
Reiterated: Hold
Price Target: $95 → $96
Current: $98.81
Upside: -2.84%
Rated: Buy
Price Target: $11 → $12
Current: $11.36
Upside: +5.63%
Reiterated: Hold
Price Target: $85
Current: $86.00
Upside: -1.16%
Reiterated: Hold
Price Target: $36 → $45
Current: $49.44
Upside: -8.98%
Reiterated: Buy
Price Target: n/a
Current: $97.34
Upside: -
Initiated Coverage: Buy
Price Target: $159
Current: $136.58
Upside: +16.42%
Reiterated: Buy
Price Target: $15 → $19
Current: $13.14
Upside: +44.60%
Reiterated: Buy
Price Target: $109
Current: $90.09
Upside: n/a